The company is iliquid and merging the NGIO entity into GNBT may create a more favorable hard asset position upon which GNBT could easier obtain a bank loan or financing which it cannot under present circumstances. All of this is pure speculation and would be an act of desperation since any loans would require the filing of current financial reports that are delinquent at present. If this rumor is true, it does nothing to raise the possibility of reemergence of the company and avoidance of default.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links